0002080765-25-000001.txt : 20251027 0002080765-25-000001.hdr.sgml : 20251027 20251024185957 ACCESSION NUMBER: 0002080765-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20251027 DATE AS OF CHANGE: 20251024 EFFECTIVENESS DATE: 20251027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Riverstone Iris Continuation Fund, L.P. CENTRAL INDEX KEY: 0002080765 ORGANIZATION NAME: EIN: 393010832 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-562087 FILM NUMBER: 251417184 BUSINESS ADDRESS: STREET 1: 712 FIFTH AVENUE, 36TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 993-0076 MAIL ADDRESS: STREET 1: 712 FIFTH AVENUE, 36TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 D 1 primary_doc.xml X0708 D LIVE 0002080765 Riverstone Iris Continuation Fund, L.P. 712 FIFTH AVENUE, 36TH FLOOR NEW YORK NY NEW YORK 10019 (212) 993-0076 DELAWARE None None Limited Partnership true 2025 Robert T. Gray c/o Riverstone Holdings LLC 712 Fifth Avenue, 36th Floor New York NY NEW YORK 10019 Director Pierre F. Lapeyre, Jr. c/o Riverstone Holdings LLC 712 Fifth Avenue, 36th Floor New York NY NEW YORK 10019 Director Senior Managing Director David M. Leuschen c/o Riverstone Holdings LLC 712 Fifth Avenue, 36th Floor New York NY NEW YORK 10019 Director Senior Managing Director N/A Riverstone Holdings LLC 712 Fifth Avenue, 36th Floor New York NY NEW YORK 10019 Promoter N/A Riverstone Iris FCV GP, LLC 712 Fifth Avenue, 36th Floor New York NY NEW YORK 10019 Promoter GP of Riverstone Iris Continuation Fund, L.P. (Main Fund Issuer) Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 false true false true true false 0 Jefferies LLC 2347 None None 520 Madison Avenue New York NY NEW YORK 10022 All States false Indefinite 0 Indefinite false 0 0 true 0 true Placement agent fees will be paid pursuant to a fee schedule based upon sales of interests to certain investors, and are disclosed in the Issuer's confidential offering materials. 0 true The investment manager is entitled to a management fee. The general partner is entitled to carried interest. The management fee and carried interest are fully discussed in the Issuer's confidential offering materials. false Riverstone Iris Continuation Fund, L.P. Thomas Smith Thomas Smith Managing Director of the GP of the Issuer 2025-10-24